Using genomics to improve drug prescribing

Genome UK: new four nations commitments to priority actions

NHS reform plans: prevention, personalisation and personal responsibility

Further pieces found in the puzzle of severe COVID-19

Innovative regulation: keeping pace with genomics and software devices

Host genomics and COVID-19: where are we now?

COPI notices extended until March 2022

Economies of scale: Genetically-targeted therapies

What does ‘good governance’ look like for genome editing?

Expanding the public and patient role in medical regulation